XML 18 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Operating activities    
Net income $ 685 $ 329
Adjustment to reconcile net income to net cash provided by operating activities    
Depreciation expense 250 209
Premium amortization on investment securities, net 29 46
Provision for loan losses 201 250
Provision for loss on other real estate owned 157
Originations of SBA loans held for sale (4,106)
Proceeds from the sales of SBA loans 4,293
Gains on sale of loans receivable (187)
Gains on sales of investment securities (107)
Gains on the sales of other real estate owned (4) (6)
ESOP compensation expense 39 39
Deferred income tax (benefit) expense (26) 107
Decrease (increase) in accrued interest receivable 101 (98)
Increase in surrender value of bank owned life insurance (74) (71)
Decrease in other assets 92 300
(Decrease) increase in accrued interest payable (2) 30
(Decrease) increase in accounts payable and other liabilities (472) 908
Net cash provided by operating activities 819 2,093
Investing activities    
Net increase in loans receivable (6,318) (8,958)
Proceeds from the sale of loans receivable 4,386 1,200
Purchases of investment securities held to maturity (1,645)
Sales of investment securities held to maturity 3,408
Principal repayments on investment securities held to maturity 721 912
Principal repayments on investment securities available for sale 444 1,373
Purchases of premises and equipment (37) (99)
Investment in other real estate owned (11) (167)
Proceeds from other real estate owned 408 327
Redemptions of Federal Home Loan Bank stock 37
Net cash used by investing activities (2,015) (2,004)
Financing activities    
Net increase (decrease) in deposits 19,649 (7,747)
Net increase in escrowed funds 297 138
Proceeds from long-term advances 1,975
Repayments of long-term advances (2,800)
Net cash provided (used) by financing activities 19,121 (7,609)
Net increase (decrease) in cash and cash equivalents 17,925 (7,520)
Cash and cash equivalents, beginning of period 15,368 22,334
Cash and cash equivalents, end of period 33,293 14,814
Supplemental disclosures of cash flow information    
Interest 1,629 1,027
Investment securities transferred from held to maturity to available for sale $ 12,619